SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro (Q39115039)

9 September 2017

title

SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro (English)

1 reference

9 September 2017

1 reference

L Wang

1 reference

9 September 2017

J Zhang

1 reference

9 September 2017

X Yang

1 reference

9 September 2017

Y W Y Chang

1 reference

9 September 2017

M Qi

1 reference

9 September 2017

Z Zhou

1 reference

9 September 2017

J Zhang

1 reference

9 September 2017

B Han

1 reference

9 September 2017

publication date

6 August 2013

1 reference

Prostate Cancer and Prostatic Diseases

9 September 2017

published in

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

301-307

1 reference

Molecular genetics of prostate cancer: new prospects for old challenges

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Molecular markers for prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

New genes involved in cancer identified by retroviral tagging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.25

31 March 2020

Identifiers

DOI

10.1038/PCAN.2013.25

1 reference

9 September 2017

1 reference